First Time Loading...

Integra Lifesciences Holdings Corp
NASDAQ:IART

Watchlist Manager
Integra Lifesciences Holdings Corp Logo
Integra Lifesciences Holdings Corp
NASDAQ:IART
Watchlist
Price: 28.75 USD -1.47% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one IART stock under the Base Case scenario is 79.51 USD. Compared to the current market price of 28.75 USD, Integra Lifesciences Holdings Corp is Undervalued by 64%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IART Relative Value
Base Case
79.51 USD
Undervaluation 64%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
98
vs Industry
58
Median 3Y
3
Median 5Y
3
Industry
2.4
Forward
1.4
More Details
33.2
P/E
P/E
Price to Earnings
33.2
vs History
50
vs Industry
16
Median 3Y
28.9
Median 5Y
33.2
Industry
23.2
Forward
8.8
More Details
16.1
P/OCF
P/OCF
Price to OCF
16.1
vs History
93
vs Industry
26
Median 3Y
18.1
Median 5Y
19.1
Industry
15.5
More Details
24.8
P/FCFE
P/FCFE
Price to FCFE
24.8
vs History
61
vs Industry
21
Median 3Y
38.2
Median 5Y
34.9
Industry
23.5
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
98
vs Industry
53
Median 3Y
2.7
Median 5Y
3.1
Industry
2.2
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
98
vs Industry
46
Median 3Y
3.6
Median 5Y
3.8
Industry
2.5
Forward
2.1
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
98
vs Industry
55
Median 3Y
5.8
Median 5Y
5.9
Industry
5.2
More Details
8.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.7
vs History
98
vs Industry
37
Median 3Y
13.9
Median 5Y
15.7
Industry
12.5
Forward
8.6
More Details
12.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.6
vs History
98
vs Industry
34
Median 3Y
19.7
Median 5Y
22.6
Industry
17.2
Forward
9.8
More Details
24.5
EV/OCF
EV/OCF
Enterprise Value to OCF
24.5
vs History
46
vs Industry
18
Median 3Y
22.4
Median 5Y
24.3
Industry
15.1
More Details
46.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
46.8
vs History
39
vs Industry
10
Median 3Y
28.4
Median 5Y
36.1
Industry
19.7
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
98
vs Industry
59
Median 3Y
1.7
Median 5Y
1.9
Industry
2
More Details

Multiples Across Competitors

IART Competitors Multiples
Integra Lifesciences Holdings Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Integra Lifesciences Holdings Corp
NASDAQ:IART
2.2B USD 1.5 33.2 8.7 12.6
US
Abbott Laboratories
NYSE:ABT
183.7B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
134B USD 18.3 67.4 55.3 69.3
US
Stryker Corp
NYSE:SYK
124.3B USD 5.9 37 24 29.6
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.3 25.6 13.6 19.3
US
Boston Scientific Corp
NYSE:BSX
105.6B USD 7.2 59.8 30.5 45
US
Becton Dickinson and Co
NYSE:BDX
69.4B USD 3.6 57 19 40.2
DE
Siemens Healthineers AG
XETRA:SHL
57.6B EUR 2.6 38 18.3 30.8
US
Edwards Lifesciences Corp
NYSE:EW
51.2B USD 8.3 36.2 26.3 28.5
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3
US
Dexcom Inc
NASDAQ:DXCM
50.2B USD 13.2 78.5 58.6 76.4

See Also

Summary
IART intrinsic value, competitors valuation, and company profile.
DCF Valuation
IART stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IART stock valuation using valuation multiples.
Wall Street Estimates
IART price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IART stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.